Gallium-68 DOTATATE ( DrugBank: Dotatate )


1 disease
IDDisease name (Link within this page)Number of trials
84Sarcoidosis2

84. Sarcoidosis


Clinical trials : 149 Drugs : 227 - (DrugBank : 81) / Drug target genes : 82 - Drug target pathways : 167
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03746847
(ClinicalTrials.gov)
December 1, 201829/10/2018PET Imaging in Patients With Suspected Cardiac SarcoidosisSomatostatin Receptor Imaging in Patients With Suspected Cardiac SarcoidosisCardiac SarcoidosisDrug: Gallium-68 DOTATATEUniversity of PennsylvaniaAdvanced Accelerator ApplicationsRecruiting18 YearsN/AAll20United States
2NCT02546388
(ClinicalTrials.gov)
October 20159/9/2015Somatostatin Receptor Imaging in Patients With Suspected Cardiac SarcoidosisSomatostatin Receptor Imaging in Patients With Suspected Cardiac SarcoidosisSarcoidosisDrug: Indium-111 Pentreotide;Drug: Gallium-68 DOTATATEMarcelo F. Di Carli, MD, FACCMallinckrodtCompleted18 Years90 YearsAll17N/AUnited States